PHILADELPHIA, Nov. 21, 2016 /PRNewswire/ -- Aberdeen Japan Equity Fund, Inc. (the "Fund") (NYSE: JEQ), a closed-end equity fund, announced today its performance data and portfolio composition as of October 31, 2016.
The Fund's total returns for various periods through October 31, 2016 are provided below. (All figures are based on distributions reinvested at the dividend reinvestment price and are stated net-of-fees):
Cumulative as of 10/31/16 |
Annualized as of 10/31/16 |
|||||||
1 Month |
3 Month |
YTD |
1 Year |
3 Years |
5 Years |
10 Years |
Since Inception |
|
NAV |
0.0 |
2.7 |
12.2 |
14.2 |
10.7 |
11.7 |
2.4 |
2.0 |
Market Price |
-0.5 |
2.1 |
6.1 |
14.1 |
8.9 |
11.0 |
1.4 |
1.3 |
TOPIX |
1.5 |
3.6 |
5.2 |
5.0 |
5.0 |
8.5 |
1.6 |
2.4 |
On October 31, 2016, the Fund's net assets amounted to US$127.9 million and the Fund's NAV per share was US$9.51.
As of October 31, 2016, the portfolio was invested as follows:
Portfolio Composition |
Percent of |
Industrials |
19.8 |
Consumer Staples |
19.4 |
Consumer Discretionary |
13.3 |
Materials |
10.5 |
Health Care |
9.4 |
Information Technology |
8.7 |
Real Estate |
6.8 |
Financials |
6.7 |
Telecommunications |
4.3 |
Cash |
1.0 |
The Fund's ten largest equity holdings as of October 31, 2016, representing 43.2% of net assets, were:
Stock |
Percent of Net Assets |
Shin-Etsu Chemical |
6.1 |
Japan Tobacco |
4.8 |
Keyence Corp. |
4.6 |
Nabtesco Corp. |
4.4 |
KDDI Corp. |
4.3 |
Seven & I Holdings |
4.2 |
Amada Holdings |
4.1 |
Fanuc |
3.6 |
Chugai Pharmaceutical |
3.5 |
Daito Trust Construction |
3.4 |
Important Information
Aberdeen Asset Management Inc. has prepared this report based on information sources believed to be accurate and reliable. All reasonable care has been taken to ensure accuracy. However, the figures are unaudited and neither the Fund, Aberdeen Asset Management Asia Limited (the Investment Manager), nor any other person guarantees their accuracy. Investors should seek their own professional advice and should consider the investment objectives, risks, charges and expenses before acting on this information.
Closed-end funds are traded on the secondary market through one of the stock exchanges. The Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that the Fund will achieve its investment objective.
Total return figures with distributions reinvested at the dividend reinvestment price are stated net-of-fees and represents past performance. Past performance is not indicative of future results, current performance may be higher or lower. Holdings are subject to change and are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities shown. Inception date July 24, 1992.
If you wish to receive this information electronically, please contact: [email protected]
Logo - http://photos.prnewswire.com/prnh/20121106/NE07292LOGO
SOURCE Aberdeen Japan Equity Fund, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article